Corcept Therapeutics Inc. vs Johnson & Johnson
CORT vs JNJ — side-by-side comparison from reported financials. CORT leads 3, JNJ leads 7 of 10 comparable metrics.
Corcept Therapeutics Inc.
CORT · Healthcare
$121.19+2.24%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | CORT | JNJ |
|---|---|---|
| Price | $121.19 | $261.79 |
| Market cap | $13.1B | $631B |
| Revenue (TTM) | $831M | $97.9B |
| Revenue growth | +23.7% | +5.6% |
| Net margin | 6.6% | 21.5% |
| Free cash flow | $107M | $22.2B |
| Net cash (debt) | $366M | ($27.8B) |
| 1-year price return | +37.2% | +37.0% |
| P/E | 237.4 | 29.9 |
| P/E vs own history (cheap-side %) | 0% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 8% | 26% |
| Altman Z-score | 44.76 | — |
| CV checks passed | 8 of 10 | 10 of 10 |
| Employees | 730 | 140,800 |
Full résumé-style profiles: CORT CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.